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Abstract
 
b
 
-Cyclodextrin (BCD), a cyclic oligosaccharide
that binds cholesterol and bile acids in vitro, has been previ-
ously shown to be an effective plasma cholesterol lowering
agent in hamsters and domestic pigs. This study examined
the effects of BCD as compared with cholestyramine on
cholesterol and bile acid metabolism in the LPN hamster
model model for cholesterol gallstones. The incidence of
cholesterol gallstones was 65% in LPN hamsters fed the
lithogenic diet, but decreased linearly with increasing
amounts of BCD in the diet to be nil at a dose of 10% BCD.
In gallbladder bile, cholesterol, phospholipid and chenode-
oxycholate concentrations, hydrophobic and lithogenic in-
dices were all significantly decreased by 10% BCD. Increases
in bile acid synthesis (
 
1
 
110%), sterol 27-hydroxylase activ-
ity (
 
1
 
106%), and biliary cholate secretion (
 
1
 
140%) were
also observed, whereas the biliary secretion of chenodeoxy-
cholate decreased (
 
2
 
43%). The fecal output of chenodeox-
ycholate and cholate (plus derivatives) was increased by
 
1
 
147 and 
 
1
 
64%, respectively, suggesting that BCD reduced
the chenodeoxycholate intestinal absorption preferentially.
Dietary cholestyramine decreased biliary bile acid concen-
tration and secretion, but dramatically increased the fecal
excretion of chenodeoxycholate and cholate plus their de-
rivatives (
 
1
 
328 and 
 
1
 
1940%, respectively). In contrast to
BCD, the resin increased the lithogenic index in bile, in-
duced black gallstones in 34% of hamsters, and stimulated
markedly the activities of HMG-CoA reductase (
 
1
 
670%),
sterol 27-hydroxylase (
 
1
 
310%), and cholesterol 7
 
a
 
-hydrox-
ylase (
 
1
 
390%).  Thus, 
 
b
 
-cyclodextrin (BCD) prevented
cholesterol gallstone formation by decreasing specifically
the reabsorption of chenodeoxycholate, stimulating its bio-
synthesis and favoring its fecal elimination. BCD had a
milder effect on lipid metabolism than cholestyramine and
does not predispose animals to black gallstones as
cholestyramine does in this animal model.
 
—Boehler, N., M.
Riottot, J. Férézou, M. Souidi, F. Milliat, C. Sérougne, J. L.
Smith, and C. Lutton.
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Beta-cyclodextrin (BCD) is a cyclic oligosaccharide con-
taining seven glucopyranose units all linked in 
 
a
 
 (1–4) po-
sition (1), produced by the enzymatic cleavage of amylo-
maize starch. Its cone-shaped structure, with a hydrophilic
surface and a hydrophobic cavity, confers a remarkable
ability of BCD to form inclusion complexes (1). In partic-
ular, BCD is able to bind and solubilize cholesterol and
bile acids in vitro (2, 3). When orally administered to rats,
this carbohydrate does not exert any measurable toxic,
genotoxic, or carcinogenic effects (4, 5). BCD absorption
by the small intestine is minimal (6, 7) with slow degrada-
tion by the microflora in the hindgut (8).
We have previously reported that BCD, added to choles-
terol-enriched diets, had a marked hypocholesterolemic
effect in rats, hamsters, and pigs. This poorly digestible
carbohydrate stimulated bile acid synthesis and modified
the bile acid species, and the results supported decreased
intestinal absorption of cholesterol (9, 10). We also re-
ported that autoclaved amylomaize starch, another poorly
digestible carbohydrate, prevented cholelithiasis in ham-
sters fed a fat-free lithogenic diet (11) by decreasing
hepatic cholesterol synthesis and increasing the transfor-
mation of cholesterol into bile acids. While a high concen-
tration of dietary amylomaize starch is necessary to produce
beneficial effects on cholesterol and bile acid metabolism,
significantly lower amounts of BCD (
 
<
 
10%) were re-
quired for comparable effects (9).
To determine the potential of BCD as an antilithiasic
agent and to further explore its effects on cholesterol and
bile acid metabolism, we have examined the effects of
BCD in LPN hamsters fed a low-fat, sucrose-based litho-
genic diet (12). In order to obtain a detailed picture of
the mechanistic actions of BCD, the following key parame-
 
Abbreviations: BCD, 
 
b
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a
 
OH, cholesterol 7
 
a
 
-
hydroxylase; S27OH, sterol 27-hydroxylase; VLDL, very low density lipo-
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ters were determined: lipid concentrations in plasma, bile,
and liver; hepatic enzyme activities of HMG-CoA reduc-
tase, cholesterol 7
 
a
 
-hydroxylase, and sterol 27-hydroxylase;
protein levels of HMG-CoA reductase, cholesterol 7
 
a
 
-
hydroxylase and LDL receptor in liver; intestinal absorp-
tion of dietary cholesterol, and the composition of bile
acids in both feces and bile. The effects of BCD were com-
pared with those of cholestyramine (CTR), a bile acid se-
questrant known to decrease plasma cholesterol in various
animal species (13) and to prevent gallstone formation in
the hamster (14).
MATERIALS AND METHODS
 
Chemicals and isotopes
 
b
 
-Cyclodextrin (Kleptose
 
®
 
, water content 12%, purity 99%)
was kindly provided by Société Roquette Frères, (62 136 Lestrem,
France). Cholestyramine was kindly provided by Bristol-Meyer-
Squibb, (92057 Paris Cedex 24, France). Kits were purchased
from Boehringer-Mannheim (Meylan, France) for the determi-
nation of cholesterol (method CHOD-PAP), and from Wako,
Oxoid (Rungis, France) for the measurement of triglycerides and
phospholipids. A polyclonal antibody raised in rabbits against the
LDL receptor purified from bovine adrenal cortex was kindly
provided by Paul Roach (Adelaide, Australia). Antibodies raised
against HMG-CoA reductase and cholesterol 7
 
a
 
-hydroxylase were
kindly provided by Gene Ness (Tampa, FL) and Roger Davis (San
Diego, CA), respectively. Deriva-sil and BSTFA were purchased
from Chrompack (Les Ulis, France) and Pierce (Rockford, IL,
USA) respectively. Intralipid 20% was purchased from Pharmacia
AB (Sweden). [1,2-
 
3
 
H]cholesterol and enhanced chemilumines-
cence reagent (ECL) were purchased from Amersham, (Les Ulis,
France), [
 
14
 
C]taurocholate sodium salt, 
 
l
 
-3-[glutaryl-3-
 
14
 
C]
hydroxymethylglutaryl coenzyme A, [5-
 
3
 
H]mevalonolactone, and
[4-
 
14
 
C]cholesterol were obtained from DuPont-NEN Products
(Les Ulis, France). LSC-cocktail for radioactivity counting, Emul-
sifier-Safe, was purchased from Packard Instrument Company
(Meriden, CT).
 
Animals and diets
 
Four-week-old male golden Syrian hamsters (
 
Mesocricetus aura-
tus
 
) from our breeding unit (designated LPN hamsters) were
randomly assigned to one of the following six semi-synthetic di-
etary groups for 30 days: lithogenic diet (LBCD0), lithogenic
diet containing 2% (L BCD2), 5% (L BCD5), or 10% (L BCD10)
BCD, 2% CTR (L CTR), or 5% lactose (L LACTOSE), in place
of sucrose. The LBCD0 is composed as follows: sucrose 67.5%,
casein 20%, lard 5%, mineral mix 5% (11), vitamin mix 2.5%
(11), without cholesterol added. Hamsters were individually
caged and had free access to food and water. Lighting condi-
tions were controlled according to a 12-h light and 12-h dark
cycle (7 
 
am
 
–7 
 
pm
 
).
 
Experimental design
 
Three experiments were performed to analyze the effect of di-
etary BCD on cholesterol lithogenesis in the hamster.
 
Experiment 1: Cholesterol and bile acid metabolism
 
Fifteen–43 hamsters per group were used. At the end of the
30-day dietary period, animals were anesthetized with an intra-
muscular injection of a solution containing Tiletamine and
Zolazepam (Zoletil 50, Virbac, 06116 Carros, France) at a dose of
100 mg/kg body weight, and were killed by collecting blood from
a heart puncture using a syringe containing heparin. Plasma was
separated from blood cells by centrifugation (10 min at 2600 
 
g
 
).
The abdomen was opened by a midline incision and the gallblad-
der was examined for the presence of gallstones. The bile was di-
rectly aspirated from the gallbladder using a calibrated plastic in-
sulin syringe (0.5 ml) fitted with a 30G needle and was diluted
(1:20) with 0.9% saline solution and stored at 
 
2
 
20
 
8
 
C for further
analysis. The liver was excised and weighed, and aliquots were
taken for cholesterol measurement, LDL receptor protein assay,
and enzymatic assays. Colon, small intestine, and cecum were
also excised, weighed, and stored at 
 
2
 
20
 
8
 
C.
 
Plasma and lipoproteins.
 
Plasma lipids were measured by enzy-
matic procedures using commercial kits. Lipoproteins were frac-
tionated by ultracentrifugation of plasma samples (0.5 ml) in a
density gradient (15), using a SW41 rotor in a L8-70 apparatus
(Beckman Instruments, Gagny, France). On the basis of the cho-
lesterol profile in the gradient, the level and the composition of
the major lipoprotein classes, i.e., very low density lipoproteins
(VLDL) and chylomicrons (VLDL 
 
1
 
 chylomicrons, d 
 
,
 
 1.010 g/
ml), low density lipoproteins (LDL, 1.010 
 
<
 
 d 
 
,
 
 1.063 g/ml),
and high density lipoproteins (HDL, 1.063 
 
<
 
 d 
 
<
 
 1.20 g/ml), were
calculated from the sum of appropriate fractions according to
their density.
 
Liver.
 
Frozen liver samples (0.5 g) were thawed and homoge-
nized in 5 ml isopropanol, using an Ultra-Turrax apparatus
( Janke & Kunkel Gmb & Co., Staufen, Germany). After incuba-
tion at 60
 
8
 
C for 1 h and centrifugation for 5 min at 3000 
 
g
 
, the su-
pernatant was collected and the pellet was re-extracted with 5 ml
isopropanol. Triglycerides and total cholesterol were measured
enzymatically on the pooled isopropanolic extracts, using the ap-
propriate assay kits. Free and esterified cholesterol were sepa-
rated by thin-layer chromatography on silica gel plates eluted
with diethyl ether, taken to dryness, and dissolved in isopropanol
prior to enzymatic cholesterol determination.
Microsomes and mitochondria were prepared from fresh liver
samples (1 g) by homogenization in 7 ml buffer (Tris/HCl 50
m
 
m
 
, sucrose 300 m
 
m
 
, DTT 10 m
 
m
 
, EDTA 10 m
 
m
 
, NaCl 50 m
 
m
 
, pH
7.4) at 4
 
8
 
C, by means of a Teflon pestle. Microsomal and mito-
chondrial fractions were isolated according to the procedure de-
scribed by Einarsson et al. (16) and Souidi et al. (17), respec-
tively. HMG-CoA reductase activity was determined, in the
microsomes, in the presence of alkaline phosphatase using the
radioisotopic technique of Philipp and Shapiro (18). Cholesterol
7
 
a
 
-hydroxylase was assayed, in the microsomal fractions, according
to a radioisotopic method using [4-
 
14
 
C]cholesterol, solubilized,
and carried by hydroxypropyl-
 
b
 
-cyclodextrin (19). An NADPH re-
generating system was used to inhibit the 3
 
b
 
-hydroxy-
 
D
 
5-C27-steroid
oxydoreductase which is able to convert 7
 
a
 
-OH-cholesterol into
7
 
a
 
-OH-4-cholesten-3-one, in the presence of NADP
 
1
 
 (19). Sterol
27-hydroxylase was assayed in the mitochondrial fractions by a
radioisotopic method using [4-
 
14
 
C]cholesterol solubilized in hy-
droxypropyl-
 
b
 
-cyclodextrin (17).
The protein levels of HMG-CoA reductase, cholesterol 7
 
a
 
-
hydroxylase, and LDL receptor were determined by immunoassay
(20). Nitrocellulose membranes containing microsomal proteins
spotted using dot-blot apparatus were incubated with specific an-
tibodies after incubation with anti-IgG antibody linked to horse-
radish peroxidase and detection was performed using enhanced
chemiluminescence reagents (ECL).
 
Bile.
 
Phospholipid and cholesterol concentrations in diluted
bile samples were measured using commercial kits. Total bile
acid concentration was estimated by an enzymatic method with
3
 
a
 
-hydroxysteroid dehydrogenase (21). The cholesterol satura-
tion index (lithogenic index) of bile was calculated according to
the method of Carey (22) and Thomas and Hofmann (23). Bile
 at Univ of Queensland (CAUL), on September 28, 2015
w
w
w
.jlr.org
D
ow
nloaded from
 
 728 Journal of Lipid Research
 
Volume 40, 1999
acid composition was determined by gas–liquid chromatography
(GLC) after deconjugation by choloylglycine hydrolase EC
3.5.1.24 (Sigma Chemical, St. Louis, MO) and extraction by di-
ethylether, methylation with diazomethane, and silylation with
deriva-sil and BSTFA. Analyses were performed on a Carlo Erba
HRGC 5160 (Thermoquest, Les Ulis, France) apparatus equipped
with a standard fused silica WCOT capillary column packed with
OV1701 (Spiral, Dijon, France) (length: 25 m, film thickness: 0.2
 
m
 
m; oven temperature: 240
 
8
 
C; flow rate of hydrogen carrier gas:
2 ml/min). Individual molecular species of conjugated bile acids
were determined by HPLC, as previously described (24) and
their molar proportions were expressed as percent of the total
bile salt concentration. Hydrophobicity index of the bile acid
pool was calculated for each bile sample on the basis of the hy-
drophobicity index previously determined for common conju-
gated bile salts (25).
 
Fecal samples.
 
Lipids of fecal samples were extracted by boiling
ethanol in a Soxhlet apparatus for 48 h. After the addition of
known amounts of radioactive markers ([1,2-
 
3
 
H]cholesterol and
[
 
14
 
C]taurocholate sodium salt), the ethanolic extract was saponi-
fied in boiling ethanolic and 2 
 
m
 
 potassium hydroxide for 3 h.
The sterol-containing unsaponifiable fraction was extracted with
petroleum ether and 
 
3
 
H radioactivity was measured in a liquid
scintillation counter. In the aqueous phase, bile acids were de-
conjugated by the method of Grundy, Ahrens, and Miettinen
(26) and extracted with diethylether. 
 
14
 
C radioactivity was used to
correct for procedural losses. Free bile acids were methylated
with diazomethane and trimethylsilyl (TMS) and the derivatives
were assayed by GLC, as described above. Neutral sterols were an-
alyzed as TMS derivatives, using an HRGC 5160 apparatus
equipped with a standard fused silica WCOT capillary column
(length, 25 m; film thickness, 0.2 
 
m
 
m) cross-linked with CPSil5CB
(Chrompack, Les Ulis, France). The oven temperature was 240
 
8
 
C
and the flow rate of hydrogen carrier gas was 2 ml/min. Molar
proportions and total amounts of sterols and bile acids were as-
sessed using calibration curves obtained from the analysis of stan-
dard mixtures (26).
 
Experiment 2: Biliary secretion of cholesterol 
and bile acids.
 
Six–7 hamsters were used per group: L BCD0, L BCD5, L
BCD10 and L CTR. Animals were anesthetized as above and gall-
bladder bile was aspirated. The common bile duct was ligated
and the cystic duct was cannulated with polyethylene tubing (PE
10) that was introduced into the gallbladder and hepatic bile was
collected for 30 min. The volume of bile secreted during collec-
tion period was determined. Phospholipid and cholesterol con-
centrations in hepatic bile samples were measured using com-
mercial kits and total bile acid concentration and cholesterol
saturation index of bile were estimated as described above.
 
Experiment 3: Intestinal absorption of cholesterol
 
Six hamsters per group were used: L BCD0, L BCD10, and L
CTR. Each hamster received an intravenous dose of approxi-
mately 2.5 
 
m
 
Ci of [1,2-
 
3
 
H]cholesterol contained in Intralipid
20%, followed by an intragastric dose of about 1.0 
 
m
 
Ci of [4-
 
14
 
C]cholesterol contained in walnut oil, according to the dual
isotope ratio method was adapted for hamsters by Turley, Hern-
don, and Dietschy (27). Seventy two hours after labeled choles-
terol administration, animals were anesthetized and killed by
collecting blood from a heart blood puncture using a syringe
containing heparin. Plasma and liver samples were taken for
the measurement of total cholesterol concentration. 
 
3
 
H and
 
14
 
C radioactivity of two plasma samples (100 
 
m
 
l each) was mea-
sured and the cholesterol absorption coefficient was calculated
as follows:
Percent cholesterol absorption 
 
5
 
Statistical analysis
 
Results are given as mean values and their SEM. Statistical dif-
ferences among the groups were determined by multivariant
analysis and the Newman-Keuls test. A value of 
 
P
 
 
 
,
 
 0.05 was con-
sidered significant.
 
RESULTS
 
Physiological status and incidence
of cholesterol gallstones
 
BCD, at doses of 2 or 5%, had no effect on the final
body weight, daily weight gain, or food intake (
 
Table 1
 
).
With a dose of 10% BCD, the cecum weight increased
markedly (4.3% of body weight versus 2.8% in L group, 
 
P
 
 
 
5
 
0.05). The feces quantity also increased in this group by a
similar magnitude (0.43 versus 0.23 g/day in L group, 
 
P
 
 
 
5
 
0.05). The addition of CTR increased food consumption
and feces excretion. Sixty-five percent of the hamsters re-
ceiving the lithogenic diet had cholesterol gallstones in
their gallbladder. The replacement of 5% sucrose by 5%
lactose did not modify the gallstone incidence. In con-
trast, the incidence of cholesterol gallstones decreased
with BCD supplementation to be nil at the 10% dose. This
incidence was inversely proportional to the concentration
of BCD in the diet when the four hamster groups were
considered (
 
r
 
 
 
5
 
 
 
20.962, P , 0.001). Although CTR also
prevented cholesterol gallstone formation, it induced pig-
mented gallstones in 34% of the hamsters, a phenomenon
not observed for BCD.
Plasma and liver lipid concentrations
Supplementation of the lithogenic diet with 10% BCD
did not modify the plasma cholesterol concentration
[1.33 6 0.04 (n 5 40) in the LBCD10 group, 1.40 6 0.04
mg/mL (n 5 43) in the LBCD0 group] whereas CTR de-
creased it by 14% (1.15 6 0.05 mg/mL, n 5 41). The
basal concentrations of plasma phospholipids and tria-
cylglycerols in LBCD0 group (2.7 6 0.1 and 1.5 6 0.2 mg/
mL, respectively) were not modified by adding 10% BCD
(2.7 6 0.1 and 1.4 6 0.2 mg/mL) or CTR (3.08 6 0.1 and
1.20 6 0.2 mg/mL) in the lithogenic diet. While BCD had
no effect on cholesterol distribution among lipoprotein
classes, CTR markedly decreased the cholesterol content of
VLDL (270%), LDL (257%) and HDL (217%) (results
not shown). In the liver, the concentrations of free and es-
terified cholesterol and triglycerides (2.0 6 0.2, 1.0 6 0.1
and 6.6 6 0.8 mg/g, respectively) in the LBCD0 group
were not significantly altered by BCD or CTR addition.
Regulators of hepatic cholesterol metabolism
The activities and the protein levels of HMG-CoA re-
ductase and of cholesterol 7a-hydroxylase and the protein
level of LDL receptor were similar for the LBCD0 and
LBCD10 groups (Table 2). However, supplementation of
Percent of intragastric C dose per plasma sample14
Percent of intravenous H dose per plasma sample3
-----------------------------------------------------------------------------------------------------------------------------------  ? 100
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L diet with 10% BCD doubled sterol 27-hydroxylase activ-
ity. In contrast, the addition of CTR increased both activity
(1674%) and protein level (1518%) of HMG-CoA reduc-
tase. CTR also increased the activities of cholesterol 7a-
hydroxylase (1387%) and of sterol 27-hydroxylase (1176%),
and raised the protein level of the LDL receptor (1114%).
Lipid concentrations of gallbladder bile
As compared to the LBCD0 diet, the LBCD5 and 10 di-
ets markedly decreased the cholesterol and phospholipid
concentrations (232% and 242%, respectively) and their
molar proportions (228 and 222%, respectively),
whereas the concentration and molar proportion of bile
acids were unchanged (Table 3). Thus, the lithogenic in-
dices determined by the method of Carey (22) and Thomas
and Hofmann (23) were significantly decreased (221%
and 223%) by the LBCD10 diet. CTR markedly de-
creased the concentration of cholesterol, phospholipids,
and bile acids (260, 271.5 and 257%, respectively). The
molar proportions for cholesterol and bile acids were un-
changed whereas that for phospholipids were decreased
(228%). The Carey lithogenic index was increased by
24% by CTR.
Hepatic secretion of biliary lipids
The volume of bile secreted per hour was not signifi-
cantly modified by the type of diet or by the addition of
BCD or CTR (Table 4). In the LBCD0 group the three
lipid concentrations in the hepatic bile were 5-fold lower
than in the gallbladder bile but the lithogenic indices
were similar. The addition of 10% BCD to the L diet in-
creased the bile acid secretion (150%), but had no effect
on cholesterol or phospholipid secretions. The lithogenic
index therefore decreased (238 and 253%, according to
Thomas and Hofmann (23) and Carey (22), respectively).
The addition of CTR to the L diet decreased both the phos-
pholipid and cholesterol secretion rates (272 and 271%,
respectively) and their concentrations (263 and 264%,
respectively). The lithogenic indices were similarly de-
creased (240%).
Composition of biliary bile acids
In the L BCD0 group, the concentrations of cholic acid
plus its derivatives and that of chenodeoxycholic acid plus
its derivatives were similar (Table 5). This similarity was
also observed with the glyco/tauroconjugated ratios of
cholic and chenodeoxycholic acids. The addition of 10%
BCD increased the concentration of cholic acid (135%)
and decreased that of chenodeoxycholic acid (268%),
leading to a markedly lower hydrophobic index (249%)
when compared with the LBCD0 diet. Moreover, the
glyco/tauroconjugated ratio increased for both the cholic
and the chenodeoxycholic acids (177% and 1103%, re-
spectively) in the LBCD10 group. The addition of CTR
tended to decrease the concentration of cholic acid and
markedly reduced that of chenodeoxycholic acid (294%),
thus decreasing the hydrophobic index (265%). In con-
trast to the effect of BCD, the glyco/tauroconjugated ratios
TABLE 1. Final body weight, cecum weight, daily weight of excreted feces, and incidence of cholesterol and black gallstones
in hamsters fed a lithogenic diet (L) supplemented with different proportions of b-cyclodextrin 
(0, 2, 5, or 10% BCD) or with 5% of lactose or with 2% cholestyramine (CTR)
Diets n Final Body Weight Cecum Weight
Daily Weight
of Excreted Feces
Number of
Hamsters with
Cholesterol Gallstones
Number of
Hamsters with
Black Gallstones
g % of body weight g/day
LBCD 0 40 69.5 6 1.2 2.8 6 0.1b 0.23 6 0.01c 26 (65%) 3 (7.5%)
LBCD 2 15 70.7 6 1.9 2.7 6 0.2b 0.42 6 0.02a,b 8 (53%) 0 (0%)
LBCD 5 25 70.9 6 1.3 2.5 6 0.2b 0.42 6 0.02a,b 4 (16%) 2 (8%)
LBCD 10 43 66.5 6 1.5 4.3 6 0.2a 0.43 6 0.03a,b 0 (0%) 1 (2%)
L Lactose 17 72.3 6 1.5 3.1 6 0.2b 0.31 6 0.02c 13 (76%) 0 (34%)
LCTR 41 67.0 6 1.7 2.8 6 0.1b 0.48 6 0.02a 2 (5%) 14 (34%)
Results are expressed as means 6 SEM, n, number of hamsters per dietary group. Values with different superscripts are significantly different as
determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05).
TABLE 2. HMG-CoA R and cholesterol 7a-hydroxylase activities and protein mass, sterol 27 hydroxylase activity, 
and LDL receptor mass in liver from hamsters fed a lithogenic diet (L) supplemented with
different proportions of BCD (0, 5, or 10%) or with 2% cholestyramine
Diets n
HMG-CoA R 
Activity
HMG-CoA R
Mass
C7aOH
Activity 
C7aOH
Mass
S27 OH
Activity
LDL
Receptor
pmol/min/mg protein AU pmol/min/mg protein AU pmol/min/mg protein AU
LBCD 0 6 47.8 6 12.6b 100.0 6 26.0b 46.9 6 6.8b 100.0 6 7.3 27.3 6 2.9c 100.0 6 13.2b
LBCD 5 6 73.5 6 9.3b 66.6 6 3.7b 49.4 6 6.9b 79.0 6 3.0 ND 117.1 6 8.7b
LBCD 10 6 51.3 6 13.7b 94.3 6 14.9b 49.4 6 6.9b 81.1 6 6.3 56.3 6 5.9b 108.7 6 8.9b
LCTR 6 370.0 6 44.3a 617.4 6 34.9a 228.4 6 12.2a 80.9 6 8.9 111.6 6 11.8a 213.5 6 18.6a
Results are expressed as means 6 SEM; n, number of hamsters per dietary group. Values with different superscripts are significantly different as
determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05). The masses are given in arbitrary units with 100 attributed to L group
(AU); ND, not determined.
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for both cholic (C) and chenodeoxycholic (CDC) acids for
the CTR group were decreased (279%).
Composition of fecal bile acids
In the LBCD0 group, primary bile acids (C 1 CDC) ac-
counted for only 5% of the total fecal elimination of bile
acids, the major part (95%) corresponding to their micro-
bial derivatives (Table 6). The fecal elimination of CDC
plus its derivatives (70.9 6 2.9% of the total) was higher
than that of C plus its derivatives. Addition of 10% BCD in-
creased the fecal elimination of total bile acids (1111%).
The effect was relatively more marked for CDC 1 deriva-
tives (1133%), as particularly highlighted by the increases
of lithocholic acid (1173%) and isolithocholic (1243%),
than for C 1 derivatives (172%). The addition of CTR into
the L diet also increased the fecal elimination of lithocholic
(1300%), isolithocholic (1114%), ursodeoxycholic acids
(188%), and deoxycholic acid (13177%). Thus, the fecal
elimination of CDC 1 derivatives was 3.7-fold greater in
LCTR than in LBCD0 groups. This phenomenon was
markedly magnified for C plus its derivatives, being 31.5-
fold higher than in LBCD0 group. Finally, the fecal elimi-
nation of total bile acids by CTR was increased 11.1-fold.
Composition of fecal neutral sterols
In the LBCD0 group, cholesterol accounted for 35% of
the fecal output of neutral sterols, the remaining part cor-
responded to its microbial derivatives (Table 7). Though
the addition of BCD did not statistically modify the fecal
elimination of cholesterol, that of its main microbial de-
rivative, the coprosterol, was reduced (240%). Therefore,
the proportion of cholesterol microbial metabolites (co-
prosterol, epicoprosterol, cholestanol) was 65% in the
LBCD0 group and 44% in the LBCD10 animals. These
differences indicate that BCD reduces the microbial deg-
radation of cholesterol. Similar to BCD, CTR markedly de-
creased the proportion of coprosterol in the total sterols
(238%) and increased the cholesterol content elimina-
tion (1675%) indicating a reduced microbial degrada-
tion of cholesterol as reflected by the proportion of cho-
lesterol metabolites in the total sterols (dropping by
14%). Moreover, in contrast to BCD, the addition of CTR
markedly increased the fecal elimination of neutral ster-
ols (1215%).
Intestinal absorption of dietary cholesterol
The addition of 10% BCD or 2% CTR to the lithogenic
diet significantly decreased the intestinal absorption coef-
ficient by 233% and 263%, respectively (percent of cho-
lesterol absorption for LBCD0: 86.2 6 8.4%, LBCD10:
57.7 6 3.7%, LCTR: 32.0 6 4.0% of the dietary choles-
terol ingested, n 5 6 per group).
DISCUSSION
Hamsters from the LPN strain are predisposed to de-
velop cholesterol gallstones when fed a sucrose-enriched
diet (11, 12, 17, 28, 29). In the lithogenic diet used in the
present study, the lipid amount (5%) and the distribution
of fatty acids are similar to that reported by Trautwein,
Siddiqui, and Hayes (30), but the cholesterol content pro-
vided by lard and casein is negligible (10 mg per 100 g)
compared with that of most lithogenic diets (300–400 mg
per 100 g) (30, 31). Under this dietary condition, LPN
hamsters differ from control animals (fed a starch-based
diet) by an enrichment of gallbladder bile in cholesterol
TABLE 3. Lipid concentrations in the gallbladder and lithogenic indices of bile in non-fasting hamsters fed a
lithogenic diet (L) supplemented with different proportions of BCD or with 2% cholestyramine
Bile Acids Phospholipids Cholesterol
Lithogenic Index
Diets n mmol/ml mol % mmol/ml mol % mmol/ml mol %
Thomas and
Hofmann (23) Carey (22)
LBCD 0 25 151.9 6 11.7a 90.7 6 0.6b 11.2 6 1.0a 6.8 6 0.5a 4.0 6 0.3a 2.5 6 0.1a 0.34 6 0.02a 0.66 6 0.04b
LBCD 5 12 129.5 6 10.1a 93.2 6 0.4a 6.5 6 0.4b 4.8 6 0.3b 2.7 6 0.2b 2.0 6 0.2ab 0.30 6 0.02ab 0.56 6 0.05bc
LBCD 10 29 133.9 6 9.1a 92.8 6 0.3a 7.6 6 0.6b 5.3 6 0.3b 2.7 6 0.3b 1.8 6 0.1b 0.27 6 0.01b 0.51 6 0.03c
LCTR 24 65.4 6 5.5b 92.7 6 0.5a 3.2 6 0.3c 4.9 6 0.4b 1.6 6 0.2b 2.4 6 0.2a 0.36 6 0.03a 0.82 6 0.07a
Results are expressed as means 6 SEM; n, number of hamsters per dietary group. Values with different superscripts are significantly different
as determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05).
TABLE 4. Hepatic biliary lipid secretions and concentrations and lithogenic index of bile in hamsters fed a lithogenic diet (L)
supplemented with different proportions of BCD (0 or 10%) or with 2% cholestyramine
Volume of 
Bile Secreted
Bile Acid Phospholipid Cholesterol
Lithogenic Index
Diets n Secretion Concentration Secretion Concentration Secretion Concentration
Thomas and
Hofmann (23) Carey (22)
ml/h mmol/h mmol/ml mmol/h mmol/ml mmol/h mmol/ml
LBCD 0 6 270.7 6 20.2 7.16 6 0.80b 27.34 6 3.63ab 0.65 6 0.18a 2.34 6 0.57a 0.24 6 0.03a 0.88 6 0.10a 0.40 6 0.03a 1.12 6 0.08a
LBCD 10 7 298.0 6 42.8 10.77 6 1.43a 37.95 6 4.87a 0.60 6 0.10a 2.02 6 0.16a 0.22 6 0.04a 0.76 6 0.11a 0.25 6 0.03b 0.53 6 0.05b
LCTR 7 227.7 6 29.7 4.0 6 0.49c 18.20 6 1.76b 0.18 6 0.06b 0.84 6 0.25b 0.07 6 0.01b 0.33 6 0.03b 0.24 6 0.03b 0.71 6 0.06b
Results are expressed as means 6 SEM; n, number of hamsters per dietary group. Values with different superscripts are significantly different as
determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05).
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and chenodeoxycholic acid, which increases bile acid hy-
drophobicity and facilitates the formation of cholesterol
gallstones (32 and unpublished data). In the present
study, we have used this LPN strain model of cholelithiasis
to examine the effects of BCD on the incidence of gall-
stones and on lipid metabolism and compared these ef-
fects with those of cholestyramine.
Effects of BCD
BCD supplementation resulted in a dose-dependent re-
duction in cholesterol gallstone formation with a 10%
BCD diet totally abolishing cholesterol gallstones. This
marked decrease is not related to the slight reduction in
dietary sucrose (necessary to include BCD) as the gall-
stone incidence is unaffected by replacing 5% sucrose
with 5% lactose, a disaccharide that is resistant to diges-
tion similar to BCD. In fact, the addition of BCD to the
lithogenic diet produced a fall in the molar proportion of
cholesterol and phospholipids in gallbladder bile, which
was reflected in a lower lithogenic index. Moreover, BCD
induced a spectacular decrease in the hydrophobic index
of the gallbladder bile, associated with two major changes
in the bile acid composition, i.e., an increased proportion
of cholic acid at the expense of chenodeoxycholic acid
and an increase in the glyco/tauroconjugation ratio of
these two bile acids. In the BCD groups compared to the
lithiasic hamsters (LBCD0), the modification of the bile
acid composition was associated with a stimulation of the
biliary secretion of bile acids, together with an increase in
both bile acid synthesis and bile acid intestinal absorption.
The fractional bile acid flow due to synthesis was doubled
in BCD-fed as compared to lithiasic hamsters, supporting
the results of previous experiments in hamsters and pigs
by our group (9, 10). The enhanced bile acid synthesis
is associated with a 2-fold stimulation in hepatic sterol
27-hydroxylase activity and no change in cholesterol 7a-
hydroxylase expression (activity and protein level), sug-
gesting a channelling of cholesterol through the acidic
bile acid pathway in BCD-fed hamsters. This hypothesis is
supported by the fecal elimination of chenodeoxycholic
and cholic acids (plus their microbial derivatives) in BCD-
fed compared with lithiasic hamsters, being 2.5- and 1.6-
fold higher, respectively. These results are consistent with
previous observations in hamsters and mice fed diets con-
taining either starch or BCD in place of sucrose (9, 33).
Taken together, these results suggest that BCD binds a
greater proportion of chenodeoxycholic than cholic acid
in the small intestine, decreasing the reabsorption of chen-
odeoxycholic acid. In vitro data also support the observa-
tion that BCD binds hydrophobic bile acids (lithocholic
and chenodeoxycholic acids) more strongly than the hy-
drophilic cholic acid (34, 35) and that this binding is
higher for tauro- versus glyco-conjugated bile acids (3).
This could partly explain the bile enrichment in glycocon-
jugated bile acids and the increased fecal output of litho-
cholic acid in BCD-fed hamsters. This latter effect may be
responsible for the minimal colonic damage by this cyto-
toxic bile acid (9, 36). The hepatic synthesis of bile acids,
as determined by the fecal bile acid elimination, and the
biliary bile acid secretion were 2.1- and 1.5-fold higher in
10% BCD-fed compared with lithiasic hamsters, respec-
tively. The secretion of bile acids by hepatocytes is the sum
TABLE 5. Gallbladder bile acid composition, glyco/tauroconjugated bile acid ratio, and hydrophobic index of bile in hamsters
fed a lithogenic diet (L) supplemented with different proportions of BCD (0, 5, or 10%) or with 2% cholestyramine
Diets n C DC CDC LC
OXO
Bile Acids
Cholate
G/T Ratio
Chenodeoxycholate
G/T Ratio
Hydrophobic
Index
mmol/l
LBCD 0 11 66.2 6 11.9b 5.6 6 1.7ab 64.3 6 11.8a 4.8 6 1.8ab 14.1 6 3.1a 3.9 6 1.0b 3.8 6 1.0b 0.37 6 0.01a
LBCD 5 8 92.5 6 7.5a 8.4 6 1.0a 16.2 6 7.1b 9.6 6 0.6a 5.1 6 2.0b 3.5 6 0.7b 2.9 6 0.6bc 0.21 6 0.01b
LBCD 10 10 89.0 6 2.2a 8.7 6 1.1a 20.4 6 1.3b 4.9 6 0.9ab 6.9 6 0.5b 6.9 6 0.4a 7.7 6 0.9a 0.19 6 0.01b
LCTR 12 45.7 6 2.1b 4.2 6 0.5b 3.7 6 0.4b 3.1 6 1.1b 5.1 6 0.6b 0.7 6 0.2c 0.8 6 0.2c 0.13 6 0.01c
Results are expressed as means 6 SEM; n, number of hamsters per dietary group. Values with different superscripts are significantly different
as determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05). LC, lithocholic acid; DC, deoxycholic acid; C, cholic acid; CDC,
chenodeoxycholic acid; G, glyco amidate moiety; T, tauro amidate moiety; G/T, ratio glyco/tauro amidate.
TABLE 6. Composition and daily fecal elimination of bile acids in hamsters fed a lithogenic diet (L)
supplemented with different proportions of BCD (0, 5, or 10%) or with 2% cholestyramine
Diets n CDC ILC LC UDC C DC
OXO
Bile Acids
Total Fecal
Elimination
mmol/day?1021 mmol/day
LBCD 0 6 0.49 6 0.07b 1.28 6 0.23bc 9.26 6 0.38c 1.81 6 0.52b 0.38 6 0.03c 4.65 6 0.62b 0.87 6 0.10b 1.87 6 0.08b,'
LBCD 5 6 0.35 6 0.03b 3.21 6 0.41ac 14.70 6 1.47c 0.39 6 0.14b 0.33 6 0.04c 6.21 6 0.71b 1.38 6 0.37b 2.66 6 0.10b,§
LBCD 10 6 0.38 6 0.04b 4.39 6 1.07a 25.28 6 2.67b 0.31 6 0.09b 0.46 6 0.04b 7.35 6 0.89b 1.59 6 0.18b 3.97 6 0.37b,“
LCTR 6 2.34 6 0.70a 2.74 6 0.52ac 36.83 6 2.90a 3.40 6 0.65a 0.84 6 0.03a 152.39 6 13.96a 8.83 6 1.53a 20.74 6 1.82a
Results are expressed as means 6 SEM; n, number of hamsters per dietary group. Values with different superscript letters are significantly dif-
ferent as determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05). In the last column, two analyses were performed, an ANOVA
in four groups (superscript letters) and an ANOVA in three groups (superscript symbols). In this latter analysis, LCTR results were eliminated be-
cause the mean and SEM were too high in comparison with other groups, which prevented an accurate statistical analysis. CDC, chenodeoxycholic
acid; ILC, isolithocholic acid; LC, lithocholic acid; UDC, ursodeoxycholic acid; C, cholic acid; DC, deoxycholic acid.
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of the flow due to bile acid synthesis (from cholesterol)
and that due to intestinal reabsorption (enterohepatic cir-
culation). As the fractional bile acid flow from synthesis is
low compared with that of secretion (37, 38), it follows that
BCD increases the bile acid reabsorption. Although it ap-
pears that BCD prevents the reabsorption of chenodeoxy-
cholic acid, the increased concentration of cholic acid in
gallbladder bile and the increased secretion of total bile
acids suggest that cholic acid reabsorption is increased. In
fact, the hydroxyl group in position 12 prevents the inclu-
sion of this bile acid in BCD, dramatically reducing BCD
affinity for cholic and deoxycholic acids (34). Moreover,
we have previously demonstrated that poorly digestible
carbohydrates, such as lactose or amylomaize starch (the
BCD precursor), increased the size of ileal villi and stimu-
lated the ileal absorption of taurocholate in rats (39–42).
Thus, our data suggest that BCD reduces the reabsorption
of chenodeoxycholic acid and enhances that of cholic
acid. In a similar manner, BCD decreases the dietary cho-
lesterol absorption, either by encapsulation of the mole-
cule (2), or by reducing its micellar solubilization.
The potent antilithiasic property of BCD demonstrated
in LPN hamsters in the present study is apparently discor-
dant with the previous results obtained in pigs in which
BCD was shown to favor the nucleation of cholesterol in
bile (10, 42). Pigs basically differ from hamsters in the
transformation of cholesterol to bile acids leading mainly
to chenodeoxycholic and hyocholic acids as primary bile
acids (43, 44). To explain the pro-nucleation property of
BCD in pigs, we think that BCD binds hyocholic acid pref-
erentially over chenodeoxycholic acid in the small intes-
tine, thus preventing the reabsorption of hyocholic acid
and its microbial degradation. In support of this notion,
gallbladder bile from BCD-fed pigs had twice the propor-
tion of chenodeoxycholic acid and half the proportion of
hyocholic plus hyodeoxycholic acids of that in control
pigs. Furthermore, the daily fecal elimination values of
chenodeoxycholic 1 lithocholic acids and that of hyo-
cholic 1 hyodeoxycholic acids in BCD-fed pigs were 3-
and 29-fold higher, respectively, than in control pigs (42).
Thus, in pigs as in hamsters, BCD diminishes specifically
the enterohepatic circulation of several bile acids, such as
hyocholic and chenodeoxycholic acids which are more
easily bound by BCD in the intestine. Consequently, BCD
supplementation enriches pig bile with chenodeoxycholic
acid and hamster bile with cholic acid. These observations
emphasize the importance of the biliary bile acid compo-
sition and suggest it is one of the primary factors involved
in the physiological process of cholelithiasis.
BCD versus cholestyramine
CTR treatment of LPN hamsters induced black pig-
mented stones as was previously described (14). CTR has
also been reported to decrease lipoprotein levels (45) and
increase HMG-CoA reductase and cholesterol 7a-hydroxy-
lase activities (46) in hamsters and these effects have been
confirmed in the present studies with LPN hamsters. In
agreement with the increased LDL receptor-dependent
LDL transport reported in hamsters treated with CTR
(45), an increase in liver LDL receptor mass is also shown
in the current study. However, none of these effects were
found after BCD ingestion, indicating that the mode of
action of BCD is somewhat different from that of CTR.
Moreover, CTR markedly decreased bile acid flow com-
pared with that of the control (245%) and 10% BCD-fed
(263%) groups. Consequently, the bile acid concentra-
tion in gallbladder bile fell relative to that of cholesterol
and phospholipids. These changes increased the litho-
genic index and may partly explain the presence of black
gallstones which are likely to contain some cholesterol
(30). Furthermore, bile acid synthesis was markedly stimu-
lated by CTR (11000%), consistent with the elevation of
both hepatic sterol 27-hydroxylase and cholesterol 7a-
hydroxylase activities. This indicates that the bile acid re-
absorption is markedly impaired by CTR, but in contrast
to BCD, CTR increased the fecal output of cholic acid
plus derivatives to a greater extent than that of chenode-
oxycholic acid plus derivatives. In vitro, the affinity of CTR
for dihydroxylated bile acids (deoxycholic and chenode-
oxycholic acids) is higher than for trihydroxylated bile
acids (47). Thus, CTR and BCD are both able to bind bile
acids, but the ability of CTR to bind dihydroxylated bile acid
is greater than that of BCD, while BCD has higher specific-
ity for chenodeoxycholic than for deoxycholic acid (34).
We speculate that the bile acid specificity of BCD also oc-
curs in vivo (lumen of small intestine) and is likely to be a
factor determining the compensatory modifications culmi-
nating in reduced cholesterol gallstone formation.
In summary, the addition of CTR or BCD to the litho-
genic diet modifies cholesterol and bile acid metabolism
in similar ways, but by markedly different degrees. Al-
though the effect of BCD on lipid metabolism is less dra-
TABLE 7. Composition, daily fecal elimination of neutral sterols in hamsters fed a lithogenic diet (L) 
supplemented with different proportions of BCD (0, 5, or 10%) or with 2% cholestyramine
Diets n CH COP EPICOP Cholestanol
Fecal 
Elimination
mmol/day
LBCD 0 6 1.82 6 0.47b 3.24 6 0.38a 0.05 6 0.01 0.05 6 0.01 5.17 6 0.65b
LBCD 5 6 1.76 6 0.18b 1.76 6 0.18b 0.10 6 0.03 0.03 6 0.01 3.59 6 0.33b
LBCD 10 6 2.49 6 0.23b 1.92 6 0.34b 0.05 6 0.01 0.05 6 0.01 4.51 6 0.48b
LCTR 6 14.12 6 0.56a 2.03 6 0.42b 0.06 6 0.01 0.60 6 0.01 16.35 6 0.34a
Results are expressed as means 6 SEM; n, number of hamsters per dietary group. Values with different super-
scripts are significantly different as determined by ANOVA and Student-Newman-Keuls post hoc test (P , 0.05).
CH, cholesterol; COP, coprosterol; EPICOP, epicoprosterol.
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matic than that of CTR, the antilithiasic effect of this car-
bohydrate is more desirable than that of the resin because
BCD does not induce black gallstones as CTR does. Many
of the differences between BCD and CTR can be attrib-
uted to the high specificity of BCD for chenodeoxycholic
in the small intestine. BCD reduces the hydrophobicity of
bile acids within the enterohepatic circulation, and thus
reduces the tendency for cholesterol nucleation in the
gallbladder bile of hamster. BCD’s low toxicity and its ben-
eficial effects (4, 5), even at low levels (1–2%), on choles-
terol and bile acid metabolism suggest it may be consid-
ered as a good alternative to the bile acid-binding resins
which are poorly tolerated by humans. Another advantage
of BCD supplementation is that it has both anti-lithiasic
and hypocholesterolemic properties, both of which have
positive beneficial outcomes for human conditions. Fur-
ther studies aimed at evaluating the effects and properties
of BCD in well-balanced diets in both animals and hu-
mans are presently being undertaken in our laboratory.
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